S-1/A: Viewbix Inc. Files Amendment No. 1 to Form S-1 for Resale of 6,256,323 Shares of Common Stock
S-1/A Registration Statement
Viewbix Inc. has filed an amendment to its Form S-1 registration statement to register the resale of up to 6,256,323 shares of its common stock by selling stockholders.
Summary
- Viewbix Inc. filed an amendment to its Form S-1 registration statement on March 24, 2025, to register the resale of up to 6,256,323 shares of its common stock.
- The shares are to be resold by selling stockholders and consist of shares issued in private placements, upon exercise of warrants, and in connection with credit facilities and a securities exchange agreement.
- The company will not receive any proceeds from the sale of these shares by the selling stockholders, but may receive proceeds from the exercise of warrants if exercised for cash.
- Viewbix has applied to list its common stock on the Nasdaq Capital Market under the symbol VBIX.
- The company's common stock is currently quoted on the OTC Markets, Pink Tier, under the symbol VBIX, with the last reported sale price on March 21, 2025, at $5.70 per share.
- The registration statement includes risk factors related to investing in Viewbix's securities, including the sale of a substantial amount of shares, conditions in Israel, and potential military reserve duty call-ups.
- The company's financial statements for the years ended December 31, 2024 and 2023, show sales of $26.941 million and $79.613 million, respectively, and net losses of $14.106 million and $8.687 million, respectively.
- The company has entered into several facility agreements and a securities exchange agreement in 2024 and 2025.
- The company effected a one-for-four reverse stock split on March 14, 2025.
- The company's authorized capital stock consists of 490,000,000 shares of common stock and 10,000,000 shares of preferred stock, both with a par value of $0.0001.
Sentiment
Score: 4
Explanation: The sentiment is neutral to slightly negative. While the company is pursuing a Nasdaq listing and has secured financing, the significant decrease in sales and substantial net losses raise concerns. The auditor's going concern warning further contributes to the negative sentiment.
Positives
- Viewbix is pursuing a Nasdaq listing, which could increase visibility and liquidity.
- The company has secured financing through various credit facilities.
- The company has expanded its operations through acquisitions, such as Metagramm Software Ltd.
Negatives
- The company experienced a significant decrease in sales from 2023 to 2024.
- The company reported substantial net losses in both 2024 and 2023.
- The company's auditor included an explanatory paragraph describing conditions that raise substantial doubt about the company's ability to continue as a going concern.
Risks
- The sale of a substantial amount of shares could adversely affect the market price of the common stock.
- Conditions in Israel, including conflicts and political instability, may impede the company's ability to operate.
- Military reserve duty call-ups of employees could disrupt operations.
- The company's auditor included an explanatory paragraph describing conditions that raise substantial doubt about the company's ability to continue as a going concern.
Future Outlook
The company intends to use the proceeds from the exercise of warrants for working capital and general corporate purposes, including the repayment of certain outstanding debts owed by us.
Industry Context
Viewbix operates in the digital advertising platform sector, which is characterized by rapid technological advancements and increasing competition. The company's expansion into ad search and digital content reflects an effort to diversify its revenue streams and adapt to changing market dynamics.
Comparison to Industry Standards
- It is difficult to compare Viewbix's results to industry standards without more specific information about its target market and business model.
- Comparable companies in the digital advertising space include The Trade Desk (TTD), Magnite (MGNI), and PubMatic (PUBM).
- These companies generally have higher revenue and market capitalization than Viewbix.
- Viewbix's reliance on credit facilities and warrant exercises for funding is not uncommon for small-cap companies in the tech sector, but it also indicates a higher level of financial risk.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Amihay Hadad | NA | Upon effectiveness of the Uplist | Resignation |
Stakeholder Impact
- Shareholders may experience dilution due to the issuance of shares and warrants.
- Employees may be affected by potential disruptions due to military reserve duty call-ups.
- Customers may be impacted by the company's ability to deliver products and services due to conditions in Israel.
Next Steps
- The company needs to secure the Nasdaq listing.
- The company needs to execute its plan to use proceeds from warrant exercises for working capital and debt repayment.
- The company needs to improve its financial performance to address the auditor's going concern warning.
Key Dates
| Date | Description |
|---|---|
| August 16, 1985 | Viewbix Inc. was incorporated in the State of Delaware under the name The InFerGene Company. |
| August 25, 1995 | A wholly owned subsidiary of InFerGene Company merged with Zaxis International, Inc., changing its name to Zaxis International, Inc. |
| January 2020 | The Company determined to reduce its operations and the size of its sales and R&D team in the Digital Advertising Platform. |
| June 18, 2024 | Prior facility agreement entered into between the Company and the June 2024 Lenders (the Prior June 2024 Facility Agreement). |
| July 3, 2024 | Viewbix entered into a definitive securities purchase agreement with a global investment firm for a private placement. |
| July 3, 2024 | The Private Placement closed. |
| July 4, 2024 | Prior facility agreement entered into between the Company and the July 2024 Lender (the Prior First July 2024 Facility Agreement). |
| July 14, 2024 | Viewbix entered into consulting agreements with certain consultants. |
| July 15, 2024 | Reverse stock split of the Companys outstanding shares of Common Stock that was effected on July 15, 2024 with a marketplace effective date of March 14, 2025. |
| July 22, 2024 | Viewbix entered into an amended and restated facility agreement for a $1 million credit facility with certain lenders. |
| July 22, 2024 | Viewbix entered into an amended and restated facility agreement for a $2.5 million credit facility with a certain lender. |
| July 25, 2024 | Viewbix entered into consulting agreements with certain consultants. |
| July 25, 2024 | Viewbix entered into an amended and restated facility agreement for a $2.5 million credit facility with a certain lender. |
| July 28, 2024 | Viewbix entered into a facility agreement for a $3.0 million credit facility with certain lenders. |
| July 31, 2024 | Viewbix entered into an amended and restated securities exchange agreement with Metagramm Software Ltd. |
| March 14, 2025 | Viewbix effected a one-for-four reverse stock split. |
| March 21, 2025 | Last reported sale price of Viewbix common stock on the OTCPK was $5.70 per share. |
| March 24, 2025 | Viewbix entered into a securities exchange agreement with Metagramm Software Ltd. and its shareholders. |
| March 24, 2025 | The transactions contemplated by the Securities Exchange Agreement closed. |
Keywords
Viewbix, common stock, resale, registration statement, warrants, credit facilities, private placement, Nasdaq, OTCPK, securities exchange agreement, Metagramm, reverse stock split, Israel, financial results, risk factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.